Drug extends life in late prostate cancer
Linkedin

Drug extends life in late prostate cancer

Aurora : CO : USA | Aug 17, 2012 at 11:58 PM PDT
Source: United Press International
XX XX
Views: Pending
 
A phase III trial of the drug Enzalutamide extended the life of advanced prostate cancer patients by an average of five months, U.S. researchers found. Study co-author Dr. Thomas Flaig, medical director of the University of Colorado Cancer Center's Clinical Investigations Shared Resource and the... FULL ARTICLE AT United Press International
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.